Bacterial host strain comprising a mutant SPR gene and having reduced TSP activity
The present invention provides a recombinant gram-negative bacterial cell comprising a mutant spr gene encoding a spr protein having a mutation at one or more amino acids selected from D133, H145, H157, N31, R62, I70, Q73, C94, S95, V98, Q99, R100, L108, Y115, V135, L136, G140, R144 and G147 and wherein the cell has reduced Tsp protein activity compared to a wild-type cell.
1. A recombinant gram-negative bacterial cell comprising:
a mutant spr gene that encodes a mutant spr protein having a mutation that is an amino acid substitution at one or more amino acids within the spr protein selected from the group consisting of D133, H145, H157, N31, R62, I70, Q73, C94, S95, V98, Q99, R100, L108, Y115, V135, L136, G140, R144, and G147, wherein the wild type spr protein has the sequence of SEQ ID NO: 21, and
a mutation in the Tsp gene that encodes a mutated Tsp protein having reduced protease activity or a mutation in the Tsp gene or regulatory sequence of the Tsp gene that reduces or eliminates expression of the Tsp protein,
wherein said mutant spr protein reduces lysis of cells containing the mutated Tsp gene.
2. The cell according to claim 1 , wherein the mutant spr gene encodes a mutant spr protein having one or more mutations selected from the group consisting of D133A, H145A, H157A, N31Y, R62C, I70T, Q73R, C94A, S95F, V98E, Q99P, R100G, L108S, Y115F, V135D, V1350, L136P, G140C, R144C, and G147C, wherein the wild type spr protein has the sequence of SEQ ID NO: 21.
3. The cell according to claim 2 , wherein the mutant spr gene encodes a mutant spr protein having one or more mutations selected from the group consisting of S95F, V98E, Y115F, D133A, V135D, V1350, and G147C, wherein the wild type spr protein has the sequence of SEQ ID NO: 21.
4. The cell according to claim 3 , wherein the mutant spr gene encodes a mutant spr protein having the mutations S95F and Y115F, wherein the wild type spr protein has the sequence of SEQ ID NO: 21.
5. The cell according to claim 2 , wherein the mutant spr gene encodes a mutant spr protein having a mutation selected from D133A, H145A, and H157A, wherein the wild type spr protein has the sequence of SEQ ID NO: 21.
6. The cell according to claim 1 , wherein the cell further comprises one or more of the following mutated genes:
a) a mutated DegP gene encoding a DegP protein having chaperone activity and reduced protease activity;
b) a mutated ptr gene, wherein the mutated ptr gene encodes a Protease III protein having reduced protease activity or is a knockout mutated ptr gene; and
c) a mutated OmpT gene, wherein the mutated OmpT gene encodes a OmpT protein having reduced protease activity or is a knockout mutated OmpT gene.
7. The cell according to claim 1 , wherein the mutation in the Tsp gene that eliminates expression of the Tsp protein comprises a knockout mutation of the Tsp gene.
8. The cell according to claim 7 , wherein the cell's genome is isogenic to a wild-type bacterial cell except for the mutated spr gene and the mutation in the Tsp gene that encodes a mutated Tsp protein having reduced protease activity or the mutation in the Tsp gene or regulatory sequence of the Tsp gene that reduces or eliminates expression of the Tsp protein.
9. The cell according to claim 1 , said cell further comprising a polynucleotide encoding a protein of interest.
10. The cell according to claim 9 , wherein the protein of interest is an antibody or an antigen binding fragment thereof.
11. The cell according to claim 10 , wherein the antibody or antigen binding fragment thereof is specific for TNF.
12. A recombinant gram-negative bacterial cell comprising:
a mutant spr gene that encodes a mutant spr protein having a mutation that is an amino acid substitution at one or more amino acids within the spr protein, and
a mutation in the Tsp gene that encodes a mutated Tsp protein having reduced protease activity or a mutation in the Tsp gene or regulatory sequence of the Tsp gene that reduces or eliminates expression of the Tsp gene, and
optionally, a polynucleotide encoding a protein of interest,
wherein the cell's genome is isogenic to a wild-type bacterial cell except for the modification required to reduce Tsp protein activity as compared to the wild-type cell, the mutated spr gene and optionally, the presence of a polynucleotide encoding a protein of interest,
wherein said mutant spr protein reduces lysis of cells containing the mutated Tsp gene.
13. The cell according to claim 12 , wherein the wild-type spr protein has the sequence of SEQ ID NO: 21, and wherein the mutant spr gene encodes a mutant spr protein having:
a) one or more mutations at one or more amino acids selected from the group consisting of N31Y, R62C, I70T, Q73R, C94A, S95F, V98E, Q99P, R100G, L108S, Y115F, D133A, V135D, V1350, L136P, G140C, R144C, H145A, G147C, H157A, and W174R;
b) one or more mutations at one or more amino acids selected from the group consisting of D133, H145, H157, N31, R62, I70, Q73, C94, S95, V98, Q99, R100, L108, Y115, V135, L136, G140, R144, and G147 and wherein the cell has reduced Tsp protein activity compared to a wild-type cell;
c) one or more mutations at one or more amino acids selected from the group consisting of D133A, H145A, H157A, N31Y, R62C, I70T, Q73R, C94A, S95F, V98E, Q99P, R100G, L108S, Y115F, V135D, V1350, L136P, G140C, R144C, and G147C;
d) one or more mutations at one or more amino acids selected from the group consisting of S95F, V98E, Y115F, D133A, V135D, V1350, and G147C;
e) the mutations S95F and Y115F; or
f) a mutation selected from D133A, H145A, and H157A.
14. The cell according to claim 12 , wherein the cell has a mutation in the Tsp gene that eliminates expression of the Tsp protein comprising a knockout mutation of the Tsp gene, wherein the knockout mutation comprises a mutation to the Tsp gene start codon and/or one or more stop codons positioned downstream of the Tsp gene start codon and upstream of the Tsp gene stop codon.
15. The cell according to claim 14 , wherein the knockout mutation of the Tsp gene comprises a restriction marker site created by a missense mutation to the Tsp gene start codon and optionally one or more further point mutations.
16. The cell according to claim 15 , wherein the knockout mutated Tsp gene comprises SEQ ID NO:3.
17. The cell according to claim 12 , wherein the cell is E. coli.
18. The cell according to claim 12 , wherein the cell further comprises a polynucleotide sequence encoding a protein of interest.
19. The cell according to claim 18 , wherein the protein of interest is an antibody or an antigen binding fragment thereof.
20. The cell according to claim 19 , wherein the antibody or antigen binding fragment thereof is specific for TNF.
21. A recombinant gram-negative bacterial cell comprising:
a mutant spr gene that encodes a mutant spr protein having a mutation that is an amino acid substitution at one or more amino acids within the spr protein, and
a mutation in the Tsp gene that encodes a mutated Tsp protein having reduced protease activity or a mutation in the Tsp gene or regulatory sequence of the Tsp gene that reduces or eliminates expression of the Tsp gene, and
a polynucleotide encoding an antibody or an antigen binding fragment thereof specific for TNF,
wherein said mutant spr protein reduces lysis of cells containing a the mutated Tsp gene.
22. The cell according to claim 21 , wherein the cell comprises a mutation in the Tsp gene that reduces or eliminates expression of the Tsp protein, said mutation comprising a knockout mutation of the Tsp gene.
23. A method for producing a protein of interest comprising culturing a recombinant gram-negative bacterial cell as defined in claim 9 in a culture medium under conditions effective to express the recombinant protein of interest and recovering the recombinant protein of interest from the periplasm of the recombinant gram-negative bacterial cell and/or the culture medium.
24. The method according to claim 23 , wherein the method further comprises recovering the protein of interest from the cell.
25. The method according to claim 24 , wherein the protein of interest is recovered from the periplasm and/or the culture supernatant obtained by separating the cultured recombinant bacterial cell from the culture medium.
26. The method according to claim 23 , wherein the protein of interest is an antibody or an antigen binding fragment thereof.
27. The method according to claim 26 , wherein the antibody or antigen binding fragment thereof is specific for TNF.